1. Home
  2. FR vs CORT Comparison

FR vs CORT Comparison

Compare FR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Industrial Realty Trust Inc.

FR

First Industrial Realty Trust Inc.

HOLD

Current Price

$62.59

Market Cap

8.4B

Sector

Real Estate

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$117.10

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FR
CORT
Founded
1993
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
9.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
FR
CORT
Price
$62.59
$117.10
Analyst Decision
Buy
Buy
Analyst Count
12
5
Target Price
$62.17
$96.50
AVG Volume (30 Days)
966.0K
1.2M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
1.66
0.09
Revenue
$727,076,000.00
$761,407,000.00
Revenue This Year
$11.27
$26.08
Revenue Next Year
$7.19
$26.98
P/E Ratio
$37.87
$1,271.89
Revenue Growth
8.58
12.79
52 Week Low
$48.74
$28.66
52 Week High
$69.88
$122.21

Technical Indicators

Market Signals
Indicator
FR
CORT
Relative Strength Index (RSI) 35.24 66.55
Support Level $59.98 $76.41
Resistance Level $63.89 $122.21
Average True Range (ATR) 1.39 5.00
MACD -0.38 -0.00
Stochastic Oscillator 0.69 81.48

Price Performance

Historical Comparison
FR
CORT

About FR First Industrial Realty Trust Inc.

First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: